Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4979637 | 0.98 | TSHR (0.57) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4979778 | 0.98 | TSHR (0.57) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL5583026 | 0.98 | TSHR (0.57) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4980379 | 0.95 | TSHR (0.51) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18071284 | 0.90 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL18071330 | 0.90 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4977814 | 0.88 | THRB (0.47) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL499777 | 0.82 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4909696 | 0.82 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4911836 | 0.82 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | KANSAI PAINT CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1798218-A1 | MONOMER COMPOUND, PROCESS FOR PRODUCING THE SAME, POLYMER THEREOF, AND WATER-BASED CURABLE COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | THEM6, PAM, WEE1 | TSHR 4460/4885THRB 3274/4885POLB 697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.